Federal Contractor Profile
Emergent Manufacturing Operations Baltimore LLC
$498M obligated·14 awards·1 agencies·2 NAICS
Federal Contracts
Showing award actions 1–11 of 11 funded award actions, most recent first.
- Contracts with positive obligations
- 14
- Funded award actions shown
- 11
- Obligations shown
- $498M
- Awarding agencies
- 1
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of July 10, 2025. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Mar 30, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120F33006 | 236210 | DEVELOPMENT OF A PLASMA-DERIVED POLYCLONAL ANTIBODY-BASED COVID-19 THERAPEUTIC | $946K |
| Mar 23, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120F33007 | 236210 | EMERGENT CIADM MANUFACTURING CAPACITY RESERVATION AND EXPANSION | $23M |
| Jan 13, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50119F33005 | 236210 | TESTING AND SHELF-LIFE EXTENSION OF USG-OWNED ADJUVANT FOR PANDEMIC PREPAREDNESS. | $900K |
| Jul 23, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120F33008 | 236210 | TO EXPAND THE PUBLIC-PRIVATE PARTNERSHIP WITH EMERGENT TO RESERVE THE CAPACITIES AND CAPABILITIES AT CONTRACTOR?S BAYVIEW CIADM FACILITY. | $30M |
| Jun 2, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50119F33005 | 236210 | TESTING AND SHELF-LIFE EXTENSION OF USG-OWNED ADJUVANT FOR PANDEMIC PREPAREDNESS. | $33K |
| May 24, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120F33007 | 236210 | EMERGENT CIADM MANUFACTURING CAPACITY RESERVATION AND EXPANSION | $628M |
| Apr 2, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120F33006 | 236210 | DEVELOPMENT OF A PLASMA-DERIVED POLYCLONAL ANTIBODY-BASED COVID-19 THERAPEUTIC | $15M |
| Dec 19, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50119F33005 | 236210 | TESTING AND SHELF-LIFE EXTENSION OF USG-OWNED ADJUVANT FOR PANDEMIC PREPAREDNESS. | $2.2M |
| Feb 10, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033004T | 236210 | DEVELOPMENT OF THE MAPP BIOPHARMACEUTICAL VIRAL HEMORRHAGIC FEVER (VHF) MCM PLATFORMIGF::OT::IGF | $7.5M |
| Sep 28, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033003T | 236210 | IGF::OT::IGF CIADM TASK ORDER FOR THE DEVELOPMENT AND MANUFACTURING OF A WHOLE VIRION INACTIVATED ZIKA VIRUS VACCINE | $1.7M |
| Jun 24, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033003T | 236210 | IGF::OT::IGF CIADM TASK ORDER FOR THE DEVELOPMENT AND MANUFACTURING OF A WHOLE VIRION INACTIVATED ZIKA VIRUS VACCINE | $18M |
Get Alerted Before Emergent Manufacturing Operations Baltimore LLC's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free